25 XP   0   0   10

ReShape Lifesciences Inc
Buy, Hold or Sell?

Let's analyse ReShape Lifesciences Inc together

PenkeI guess you are interested in ReShape Lifesciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ReShape Lifesciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ReShape Lifesciences Inc

I send you an email if I find something interesting about ReShape Lifesciences Inc.

Quick analysis of ReShape Lifesciences Inc (30 sec.)










What can you expect buying and holding a share of ReShape Lifesciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.28
Expected worth in 1 year
$0.24
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.05
Return On Investment
-27.8%

For what price can you sell your share?

Current Price per Share
$0.17
Expected price per share
$0.1456 - $0.209
How sure are you?
50%

1. Valuation of ReShape Lifesciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.17

Intrinsic Value Per Share

$-6.75 - $-4.02

Total Value Per Share

$-6.47 - $-3.74

2. Growth of ReShape Lifesciences Inc (5 min.)




Is ReShape Lifesciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$6.6m$16.1m-$10.3m-179.6%

How much money is ReShape Lifesciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$10.1m$7.5m290.1%
Net Profit Margin-122.6%-350.9%--

How much money comes from the company's main activities?

3. Financial Health of ReShape Lifesciences Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#245 / 334

Most Revenue
#242 / 334

Most Profit
#181 / 334

Most Efficient
#254 / 334

What can you expect buying and holding a share of ReShape Lifesciences Inc? (5 min.)

Welcome investor! ReShape Lifesciences Inc's management wants to use your money to grow the business. In return you get a share of ReShape Lifesciences Inc.

What can you expect buying and holding a share of ReShape Lifesciences Inc?

First you should know what it really means to hold a share of ReShape Lifesciences Inc. And how you can make/lose money.

Speculation

The Price per Share of ReShape Lifesciences Inc is $0.1681. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ReShape Lifesciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ReShape Lifesciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.28. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ReShape Lifesciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-43.1%-0.11-66.1%-0.43-257.8%-0.45-269.6%-0.43-255.7%
Usd Book Value Change Per Share0.000.0%-0.01-6.9%-0.41-242.9%-0.05-27.8%-0.01-6.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.01-6.9%-0.41-242.9%-0.05-27.8%-0.01-6.7%
Usd Price Per Share0.18-0.56-2.55-1.72-2.48-
Price to Earnings Ratio-0.64--1.14--2.14--1.57--2.08-
Price-to-Total Gains Ratio-11.52-0.99--5.67-0.20-
Price to Book Ratio0.65-2.31-12.93-3.80-4.70-
Price-to-Total Gains Ratio-11.52-0.99--5.67-0.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1681
Number of shares5948
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.05
Usd Total Gains Per Share-0.01-0.05
Gains per Quarter (5948 shares)-69.42-277.79
Gains per Year (5948 shares)-277.66-1,111.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-278-2880-1111-1121
20-555-5660-2222-2232
30-833-8440-3333-3343
40-1111-11220-4445-4454
50-1388-14000-5556-5565
60-1666-16780-6667-6676
70-1944-19560-7778-7787
80-2221-22340-8889-8898
90-2499-25120-10000-10009
100-2777-27900-11111-11120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.069.00.00.0%
Book Value Change Per Share1.02.01.025.0%4.06.02.033.3%5.013.02.025.0%13.025.02.032.5%26.041.02.037.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.069.00.0%
Total Gains per Share1.02.01.025.0%4.06.02.033.3%5.013.02.025.0%13.025.02.032.5%26.041.02.037.7%

Fundamentals of ReShape Lifesciences Inc

About ReShape Lifesciences Inc

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Fundamental data was last updated by Penke on 2024-04-12 17:32:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ReShape Lifesciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ReShape Lifesciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -85.7% means that $-0.86 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ReShape Lifesciences Inc:

  • The MRQ is -85.7%. The company is making a huge loss. -2
  • The TTM is -122.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-85.7%TTM-122.6%+36.9%
TTM-122.6%YOY-350.9%+228.4%
TTM-122.6%5Y-373.1%+250.5%
5Y-373.1%10Y-2,118.2%+1,745.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-85.7%-12.4%-73.3%
TTM-122.6%-20.4%-102.2%
YOY-350.9%-14.8%-336.1%
5Y-373.1%-21.3%-351.8%
10Y-2,118.2%-25.0%-2,093.2%
1.1.2. Return on Assets

Shows how efficient ReShape Lifesciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • -15.8% Return on Assets means that ReShape Lifesciences Inc generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ReShape Lifesciences Inc:

  • The MRQ is -15.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.8%TTM-26.6%+10.8%
TTM-26.6%YOY-57.4%+30.8%
TTM-26.6%5Y-36.3%+9.7%
5Y-36.3%10Y-37.9%+1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.8%-4.1%-11.7%
TTM-26.6%-4.7%-21.9%
YOY-57.4%-4.8%-52.6%
5Y-36.3%-4.0%-32.3%
10Y-37.9%-5.2%-32.7%
1.1.3. Return on Equity

Shows how efficient ReShape Lifesciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • -25.5% Return on Equity means ReShape Lifesciences Inc generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ReShape Lifesciences Inc:

  • The MRQ is -25.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -54.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.5%TTM-54.4%+28.9%
TTM-54.4%YOY-143.5%+89.2%
TTM-54.4%5Y-68.2%+13.8%
5Y-68.2%10Y-86.3%+18.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.5%-4.2%-21.3%
TTM-54.4%-5.8%-48.6%
YOY-143.5%-5.7%-137.8%
5Y-68.2%-6.3%-61.9%
10Y-86.3%-7.1%-79.2%

1.2. Operating Efficiency of ReShape Lifesciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ReShape Lifesciences Inc is operating .

  • Measures how much profit ReShape Lifesciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • An Operating Margin of -95.6% means the company generated $-0.96  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ReShape Lifesciences Inc:

  • The MRQ is -95.6%. The company is operating very inefficient. -2
  • The TTM is -110.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-95.6%TTM-110.5%+14.9%
TTM-110.5%YOY-173.1%+62.6%
TTM-110.5%5Y-122.4%+11.9%
5Y-122.4%10Y-1,991.0%+1,868.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-95.6%-24.3%-71.3%
TTM-110.5%-16.4%-94.1%
YOY-173.1%-13.7%-159.4%
5Y-122.4%-19.9%-102.5%
10Y-1,991.0%-24.5%-1,966.5%
1.2.2. Operating Ratio

Measures how efficient ReShape Lifesciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.96 means that the operating costs are $1.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ReShape Lifesciences Inc:

  • The MRQ is 1.956. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.300. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.956TTM2.300-0.344
TTM2.300YOY3.338-1.037
TTM2.3005Y2.643-0.343
5Y2.64310Y21.047-18.404
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9561.442+0.514
TTM2.3001.439+0.861
YOY3.3381.431+1.907
5Y2.6431.436+1.207
10Y21.0471.374+19.673

1.3. Liquidity of ReShape Lifesciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ReShape Lifesciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.73 means the company has $2.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ReShape Lifesciences Inc:

  • The MRQ is 2.726. The company is able to pay all its short-term debts. +1
  • The TTM is 2.375. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.726TTM2.375+0.351
TTM2.375YOY1.814+0.562
TTM2.3755Y1.806+0.570
5Y1.80610Y2.331-0.525
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7262.7260.000
TTM2.3752.732-0.357
YOY1.8143.510-1.696
5Y1.8063.617-1.811
10Y2.3313.499-1.168
1.3.2. Quick Ratio

Measures if ReShape Lifesciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • A Quick Ratio of 1.65 means the company can pay off $1.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ReShape Lifesciences Inc:

  • The MRQ is 1.646. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.101. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.646TTM1.101+0.545
TTM1.101YOY1.096+0.005
TTM1.1015Y1.037+0.064
5Y1.03710Y3.062-2.026
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6461.491+0.155
TTM1.1011.633-0.532
YOY1.0962.113-1.017
5Y1.0372.295-1.258
10Y3.0622.255+0.807

1.4. Solvency of ReShape Lifesciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ReShape Lifesciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ReShape Lifesciences Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.38 means that ReShape Lifesciences Inc assets are financed with 37.9% credit (debt) and the remaining percentage (100% - 37.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ReShape Lifesciences Inc:

  • The MRQ is 0.379. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.448. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.448-0.069
TTM0.448YOY0.422+0.026
TTM0.4485Y0.478-0.030
5Y0.47810Y0.476+0.002
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.389-0.010
TTM0.4480.386+0.062
YOY0.4220.335+0.087
5Y0.4780.442+0.036
10Y0.4760.461+0.015
1.4.2. Debt to Equity Ratio

Measures if ReShape Lifesciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 61.0% means that company has $0.61 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ReShape Lifesciences Inc:

  • The MRQ is 0.610. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.877. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.610TTM0.877-0.267
TTM0.877YOY0.951-0.074
TTM0.8775Y0.900-0.023
5Y0.90010Y1.031-0.131
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6100.551+0.059
TTM0.8770.554+0.323
YOY0.9510.479+0.472
5Y0.9000.622+0.278
10Y1.0310.674+0.357

2. Market Valuation of ReShape Lifesciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings ReShape Lifesciences Inc generates.

  • Above 15 is considered overpriced but always compare ReShape Lifesciences Inc to the Medical Devices industry mean.
  • A PE ratio of -0.64 means the investor is paying $-0.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ReShape Lifesciences Inc:

  • The EOD is -0.581. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.637. Based on the earnings, the company is expensive. -2
  • The TTM is -1.136. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.581MRQ-0.637+0.056
MRQ-0.637TTM-1.136+0.499
TTM-1.136YOY-2.136+1.000
TTM-1.1365Y-1.567+0.431
5Y-1.56710Y-2.078+0.511
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.581-1.077+0.496
MRQ-0.637-1.704+1.067
TTM-1.136-2.081+0.945
YOY-2.136-2.978+0.842
5Y-1.567-2.379+0.812
10Y-2.078-1.726-0.352
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ReShape Lifesciences Inc:

  • The EOD is -0.401. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.440. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.761. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.401MRQ-0.440+0.039
MRQ-0.440TTM-0.761+0.321
TTM-0.761YOY-4.355+3.593
TTM-0.7615Y-3.589+2.828
5Y-3.58910Y-3.578-0.011
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.401-0.932+0.531
MRQ-0.440-1.578+1.138
TTM-0.761-2.973+2.212
YOY-4.355-6.318+1.963
5Y-3.589-5.307+1.718
10Y-3.578-5.171+1.593
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ReShape Lifesciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.65 means the investor is paying $0.65 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of ReShape Lifesciences Inc:

  • The EOD is 0.592. Based on the equity, the company is cheap. +2
  • The MRQ is 0.649. Based on the equity, the company is cheap. +2
  • The TTM is 2.313. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.592MRQ0.649-0.057
MRQ0.649TTM2.313-1.664
TTM2.313YOY12.928-10.614
TTM2.3135Y3.798-1.485
5Y3.79810Y4.697-0.899
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.5921.876-1.284
MRQ0.6492.372-1.723
TTM2.3132.434-0.121
YOY12.9283.217+9.711
5Y3.7983.893-0.095
10Y4.6974.245+0.452
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of ReShape Lifesciences Inc.

3.1. Institutions holding ReShape Lifesciences Inc

Institutions are holding 1.966% of the shares of ReShape Lifesciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31TWO SIGMA SECURITIES, LLC0.32220.00027557961777447.5946
2023-12-31Virtu Financial LLC0.31350.00147353254931295.3121
2023-12-31Susquehanna International Group, LLP0.2517059038590380
2023-12-31Vanguard Group Inc0.212604987400
2023-12-31BlackRock Inc0.145203406000
2023-12-31Millennium Management LLC0.0903021178211780
2023-12-31Geode Capital Management, LLC0.078201834800
2023-12-31Tower Research Capital LLC0.07280.00011706913628396.0477
2023-12-31State Street Corporation0.055501301500
2023-12-31Qube Research & Technologies0.002105005000
2023-12-31Wells Fargo & Co0.0004010177320.8333
2023-12-31Advisor Group Holdings, Inc.005-5-50
2023-12-31Group One Trading, LP00300
2023-12-31UBS Group AG002-1719-99.8838
2023-12-31Baader Bank INC000-42050-100
2023-12-31Renaissance Technologies Corp000-20500-100
2023-09-30Morgan Stanley - Brokerage Accounts000-1-100
2023-12-31Cornerstone Planning Group LLC000-135-100
2023-09-30JPMorgan Chase & Co000-1859-100
2023-12-31Armistice Capital, LLC000-188000-100
Total 1.54450.0017362304-43140-11.9%

3.2. Funds holding ReShape Lifesciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.212604987400
2023-09-30BlackRock Extended Mkt Composite0.14520.00013406000
2024-03-31BlackRock Extended Equity Market K0.1267029725110.037
2024-02-29Fidelity Extended Market Index0.075901779900
2024-02-29Fintech Income SICAV0.05550.03331302400
2024-02-29Cinvest Multigestión Garp FI0.05540.0281300000
2024-03-31Extended Equity Market Fund M0.015603667-7-0.1905
2024-02-29Fidelity Series Total Market Index0.0019044800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0018041500
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0014033310.3012
2023-12-31Northern Trust Extended Eq Market Idx0.0011025300
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0011025300
2024-02-29Spartan Total Market Index Pool E0.0004010100
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000101300
2023-12-31SSgA U.S. Extended Market Index Class I00400
2024-03-31State St US Extended Mkt Indx NL Cl C00400
2023-12-31SSgA U.S. Total Market Index Strategy00100
Total 0.69470.0614162974+5+0.0%

3.3. Insider Transactions

Insiders are holding 11.164% of the shares of ReShape Lifesciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-10-25Thomas StankovichSELL1310.27
2023-10-11Thomas StankovichSELL390.93
2023-09-01Thomas StankovichSELL1180.89
2023-08-24Thomas StankovichSELL391.42
2023-08-04Thomas StankovichSELL1081.43
2023-07-06Thomas StankovichSELL1061.47
2023-06-30Thomas StankovichBUY177021.52
2023-05-31Thomas StankovichSELL982.41
2023-04-30Thomas StankovichSELL962.36

4. Summary

4.1. Key Performance Indicators

The key performance indicators of ReShape Lifesciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0120%-0.4080%-0.0470%-0.0110%
Book Value Per Share--0.2840.247+15%0.690-59%0.904-69%0.917-69%
Current Ratio--2.7262.375+15%1.814+50%1.806+51%2.331+17%
Debt To Asset Ratio--0.3790.448-15%0.422-10%0.478-21%0.476-20%
Debt To Equity Ratio--0.6100.877-30%0.951-36%0.900-32%1.031-41%
Dividend Per Share----0%-0%-0%-0%
Eps---0.072-0.111+53%-0.433+499%-0.453+526%-0.430+494%
Free Cash Flow Per Share---0.105-0.153+46%-0.210+101%-0.152+45%-0.199+90%
Free Cash Flow To Equity Per Share--0.128-0.017+113%-0.068+153%0.034+276%-0.030+123%
Gross Profit Margin--1.8231.488+23%1.382+32%1.276+43%1.138+60%
Intrinsic Value_10Y_max---4.020--------
Intrinsic Value_10Y_min---6.750--------
Intrinsic Value_1Y_max---0.682--------
Intrinsic Value_1Y_min---0.782--------
Intrinsic Value_3Y_max---1.837--------
Intrinsic Value_3Y_min---2.272--------
Intrinsic Value_5Y_max---2.735--------
Intrinsic Value_5Y_min---3.666--------
Market Cap3943121.700-10%4325479.46713206882.526-67%59739701.175-93%40268984.775-89%58197638.505-93%
Net Profit Margin---0.857-1.226+43%-3.509+310%-3.731+335%-21.182+2373%
Operating Margin---0.956-1.105+16%-1.731+81%-1.224+28%-19.910+1982%
Operating Ratio--1.9562.300-15%3.338-41%2.643-26%21.047-91%
Pb Ratio0.592-10%0.6492.313-72%12.928-95%3.798-83%4.697-86%
Pe Ratio-0.581+9%-0.637-1.136+78%-2.136+235%-1.567+146%-2.078+226%
Price Per Share0.168-10%0.1840.563-67%2.547-93%1.717-89%2.481-93%
Price To Free Cash Flow Ratio-0.401+9%-0.440-0.761+73%-4.355+889%-3.589+715%-3.578+713%
Quick Ratio--1.6461.101+50%1.096+50%1.037+59%3.062-46%
Return On Assets---0.158-0.266+68%-0.574+263%-0.363+129%-0.379+139%
Return On Equity---0.255-0.544+113%-1.435+463%-0.682+168%-0.863+239%
Total Gains Per Share----0.0120%-0.4080%-0.0470%-0.0110%
Usd Book Value--6663000.0005786750.000+15%16181250.000-59%21209550.000-69%21500391.475-69%
Usd Book Value Change Per Share----0.0120%-0.4080%-0.0470%-0.0110%
Usd Book Value Per Share--0.2840.247+15%0.690-59%0.904-69%0.917-69%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.072-0.111+53%-0.433+499%-0.453+526%-0.430+494%
Usd Free Cash Flow---2457000.000-3598000.000+46%-4929000.000+101%-3560350.000+45%-4677704.600+90%
Usd Free Cash Flow Per Share---0.105-0.153+46%-0.210+101%-0.152+45%-0.199+90%
Usd Free Cash Flow To Equity Per Share--0.128-0.017+113%-0.068+153%0.034+276%-0.030+123%
Usd Market Cap3943121.700-10%4325479.46713206882.526-67%59739701.175-93%40268984.775-89%58197638.505-93%
Usd Price Per Share0.168-10%0.1840.563-67%2.547-93%1.717-89%2.481-93%
Usd Profit---1698000.000-2605750.000+53%-10165250.000+499%-11991800.000+606%-10688457.050+529%
Usd Revenue--1982000.0002093250.000-5%2771750.000-28%2975800.000-33%1662425.075+19%
Usd Total Gains Per Share----0.0120%-0.4080%-0.0470%-0.0110%
 EOD+2 -5MRQTTM+23 -6YOY+20 -95Y+20 -910Y+20 -9

4.2. Fundamental Score

Let's check the fundamental score of ReShape Lifesciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.581
Price to Book Ratio (EOD)Between0-10.592
Net Profit Margin (MRQ)Greater than0-0.857
Operating Margin (MRQ)Greater than0-0.956
Quick Ratio (MRQ)Greater than11.646
Current Ratio (MRQ)Greater than12.726
Debt to Asset Ratio (MRQ)Less than10.379
Debt to Equity Ratio (MRQ)Less than10.610
Return on Equity (MRQ)Greater than0.15-0.255
Return on Assets (MRQ)Greater than0.05-0.158
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of ReShape Lifesciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.519
Ma 20Greater thanMa 500.169
Ma 50Greater thanMa 1000.168
Ma 100Greater thanMa 2000.207
OpenGreater thanClose0.167
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,727
Total Liabilities4,064
Total Stockholder Equity6,663
 As reported
Total Liabilities 4,064
Total Stockholder Equity+ 6,663
Total Assets = 10,727

Assets

Total Assets10,727
Total Current Assets10,296
Long-term Assets431
Total Current Assets
Cash And Cash Equivalents 4,559
Net Receivables 1,659
Inventory 3,741
Other Current Assets 337
Total Current Assets  (as reported)10,296
Total Current Assets  (calculated)10,296
+/-0
Long-term Assets
Property Plant Equipment 310
Long-term Assets Other 29
Long-term Assets  (as reported)431
Long-term Assets  (calculated)339
+/- 92

Liabilities & Shareholders' Equity

Total Current Liabilities3,777
Long-term Liabilities287
Total Stockholder Equity6,663
Total Current Liabilities
Short-term Debt 111
Accounts payable 1,689
Other Current Liabilities 1,338
Total Current Liabilities  (as reported)3,777
Total Current Liabilities  (calculated)3,138
+/- 639
Long-term Liabilities
Long-term Liabilities  (as reported)287
Long-term Liabilities  (calculated)0
+/- 287
Total Stockholder Equity
Common Stock23
Retained Earnings -635,574
Accumulated Other Comprehensive Income -88
Other Stockholders Equity 642,302
Total Stockholder Equity (as reported)6,663
Total Stockholder Equity (calculated)6,663
+/-0
Other
Cash and Short Term Investments 4,559
Common Stock Shares Outstanding 23,457
Current Deferred Revenue639
Liabilities and Stockholders Equity 10,727
Net Debt -4,297
Net Working Capital 6,519
Short Long Term Debt Total 262



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-31
> Total Assets 
0
0
0
11,561
0
0
0
36,064
0
0
24,658
59,051
50,090
40,394
30,328
28,279
37,181
36,619
28,639
16,214
16,180
11,770
14,743
38,687
33,677
29,069
36,998
32,486
24,554
30,524
30,723
26,096
33,223
26,881
24,664
26,388
27,552
24,410
18,886
14,386
14,336
7,884
15,010
11,587
14,855
14,988
10,576
7,041
21,710
42,520
55,183
88,705
78,568
50,512
47,054
46,273
47,423
43,690
44,183
39,656
37,558
37,144
36,591
37,061
36,016
120,000
90,698
54,258
54,258
41,925
28,456
11,142
16,352
11,852
7,827
10,663
10,727
10,72710,6637,82711,85216,35211,14228,45641,92554,25854,25890,698120,00036,01637,06136,59137,14437,55839,65644,18343,69047,42346,27347,05450,51278,56888,70555,18342,52021,7107,04110,57614,98814,85511,58715,0107,88414,33614,38618,88624,41027,55226,38824,66426,88133,22326,09630,72330,52424,55432,48636,99829,06933,67738,68714,74311,77016,18016,21428,63936,61937,18128,27930,32840,39450,09059,05124,6580036,06400011,561000
   > Total Current Assets 
0
0
0
10,882
0
0
0
34,955
0
0
22,880
57,554
48,627
39,013
28,961
26,794
35,803
35,335
27,393
15,102
15,157
10,711
13,655
37,804
32,874
28,327
36,361
31,567
23,623
29,492
29,637
24,404
31,534
25,270
23,138
24,989
26,146
22,914
17,427
13,024
13,022
6,534
13,895
10,502
13,950
14,120
9,539
5,721
20,854
13,261
25,605
13,937
5,322
5,330
2,664
8,719
9,232
12,631
13,673
10,109
8,508
8,545
8,150
8,944
8,250
65,605
37,589
30,255
30,255
19,487
13,573
9,911
15,231
10,544
7,399
10,296
10,296
10,29610,2967,39910,54415,2319,91113,57319,48730,25530,25537,58965,6058,2508,9448,1508,5458,50810,10913,67312,6319,2328,7192,6645,3305,32213,93725,60513,26120,8545,7219,53914,12013,95010,50213,8956,53413,02213,02417,42722,91426,14624,98923,13825,27031,53424,40429,63729,49223,62331,56736,36128,32732,87437,80413,65510,71115,15715,10227,39335,33535,80326,79428,96139,01348,62757,55422,8800034,95500010,882000
       Cash And Cash Equivalents 
0
0
0
10,719
0
0
0
17,536
0
0
15,885
48,732
41,470
35,059
19,601
21,055
34,320
34,567
27,052
14,618
14,554
10,078
12,554
30,841
29,955
27,214
32,439
28,488
20,518
26,551
27,215
22,309
29,395
23,088
21,142
23,297
24,436
21,665
16,270
11,619
11,432
4,799
12,261
7,927
11,154
11,517
6,842
3,311
18,681
11,198
23,433
10,163
842
1,863
473
5,548
1,828
4,355
7,717
2,935
2,117
1,526
1,857
2,957
896
40,163
29,243
22,765
22,765
11,494
6,146
3,855
8,983
4,567
1,449
4,459
4,559
4,5594,4591,4494,5678,9833,8556,14611,49422,76522,76529,24340,1638962,9571,8571,5262,1172,9357,7174,3551,8285,5484731,86384210,16323,43311,19818,6813,3116,84211,51711,1547,92712,2614,79911,43211,61916,27021,66524,43623,29721,14223,08829,39522,30927,21526,55120,51828,48832,43927,21429,95530,84112,55410,07814,55414,61827,05234,56734,32021,05519,60135,05941,47048,73215,8850017,53600010,719000
       Short-term Investments 
0
0
0
0
0
0
0
17,196
0
0
6,679
8,299
6,416
3,495
9,010
5,240
888
282
0
0
0
0
0
6,527
2,000
200
3,006
1,005
1,003
1,001
200
200
200
200
200
0
0
0
0
0
0
0
0
0
0
0
11,829
2,500
25,008
54,898
41,289
23,292
0
997
8,116
2,548
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000002,5488,116997023,29241,28954,89825,0082,50011,829000000000002002002002002001,0011,0031,0053,0062002,0006,527000002828885,2409,0103,4956,4168,2996,6790017,1960000000
       Net Receivables 
0
0
0
22
0
0
0
156
0
0
71
96
38
34
86
77
24
4
0
10
15
183
781
0
0
0
0
0
123
17
53
52
19
17
53
18
0
0
0
3
1
113
25
58
55
183
192
144
68
109
333
489
962
446
532
917
3,919
4,625
2,971
4,096
3,099
2,883
2,951
2,620
3,373
3,422
3,457
2,815
2,815
2,448
2,230
2,180
2,125
2,038
2,208
1,659
1,659
1,6591,6592,2082,0382,1252,1802,2302,4482,8152,8153,4573,4223,3732,6202,9512,8833,0994,0962,9714,6253,91991753244696248933310968144192183555825113130001853171952531712300000781183151004247786343896710015600022000
       Other Current Assets 
0
0
0
142
0
0
0
68
0
0
245
427
703
424
264
422
570
482
341
474
589
449
12,554
6,964
919
27,214
35,445
1,005
976
27,552
27,215
772
784
807
770
547
619
353
242
422
463
338
233
831
874
11,517
6,842
3,311
402
537
252
468
723
920
601
1,270
174
190
123
165
206
474
1,304
1,073
241
257
347
238
188
197
157
184
530
112
94
126
337
337126941125301841571971882383472572411,0731,3044742061651231901741,2706019207234682525374023,3116,84211,51787483123333846342224235361954777080778477227,21527,5529761,00535,44527,2149196,96412,5544495894743414825704222644247034272450068000142000
   > Long-term Assets 
0
0
0
679
0
0
0
1,109
0
0
1,778
1,497
1,463
1,381
1,367
1,485
1,378
1,284
1,246
1,112
1,023
1,059
1,088
883
803
742
637
919
930
1,032
1,086
1,692
1,689
1,611
1,526
1,399
1,406
1,496
1,460
1,362
1,314
1,350
1,115
1,085
905
868
1,037
1,320
856
29,259
29,578
74,768
73,245
45,182
44,390
37,554
38,191
31,059
30,510
29,547
29,050
28,599
28,441
28,117
27,766
54,395
53,109
24,003
24,003
22,438
14,883
1,231
1,121
1,308
428
367
431
4313674281,3081,1211,23114,88322,43824,00324,00353,10954,39527,76628,11728,44128,59929,05029,54730,51031,05938,19137,55444,39045,18273,24574,76829,57829,2598561,3201,0378689051,0851,1151,3501,3141,3621,4601,4961,4061,3991,5261,6111,6891,6921,0861,0329309196377428038831,0881,0591,0231,1121,2461,2841,3781,4851,3671,3811,4631,4971,778001,109000679000
       Property Plant Equipment 
0
0
0
643
0
0
0
1,102
0
0
1,470
1,492
1,458
1,376
1,292
1,264
1,176
1,100
1,054
966
886
907
937
742
670
617
568
630
625
650
630
610
592
564
632
577
537
491
462
482
447
416
367
326
298
259
228
201
172
240
196
439
349
303
181
64
1,117
990
834
774
698
712
971
1,049
1,108
2,220
2,052
1,720
1,720
1,225
1,151
869
758
956
344
310
310
3103103449567588691,1511,2251,7201,7202,0522,2201,1081,0499717126987748349901,117641813033494391962401722012282592983263674164474824624915375776325645926106306506256305686176707429379078869661,0541,1001,1761,2641,2921,3761,4581,4921,470001,102000643000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,398
6,398
27,187
27,187
0
0
0
0
0
0
0
0
0
0
0
0
21,623
21,053
0
0
0
0
0
0
0
0
0
0
000000000021,05321,62300000000000027,18727,1876,3986,3980000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,886
21,842
46,153
45,477
44,802
44,127
36,927
36,511
29,506
29,090
28,674
28,257
27,841
27,424
27,022
26,612
28,924
28,469
20,827
20,827
19,915
12,513
260
249
238
0
0
0
00023824926012,51319,91520,82720,82728,46928,92426,61227,02227,42427,84128,25728,67429,09029,50636,51136,92744,12744,80245,47746,15321,84221,8860000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
37
0
0
0
6
0
0
308
5
5
5
75
221
202
0
0
146
136
153
151
141
133
126
68
289
305
382
456
1,082
1,097
0
894
821
869
1,006
997
880
867
934
748
758
607
609
809
1,119
684
29,018
29,382
990
232
77
82
563
563
563
586
99
95
46
46
46
46
1,628
1,535
1,456
1,377
1,298
1,219
102
114
114
0
0
0
0001141141021,2191,2981,3771,4561,5351,628464646469599586563563563827723299029,38229,0186841,1198096096077587489348678809971,00686982189401,0971,08245638230528968126133141151153136146002022217555530800600037000
> Total Liabilities 
0
0
0
9,586
0
0
0
7,490
0
0
11,656
13,769
12,695
13,597
13,156
16,874
18,274
27,325
25,285
10,633
10,058
8,871
9,035
8,980
8,442
8,643
9,733
12,445
9,422
13,332
13,911
14,221
14,520
13,039
12,263
11,709
10,321
9,737
8,419
7,722
7,021
6,453
7,268
7,914
16,114
18,597
9,421
4,102
3,764
4,515
4,136
12,338
12,694
11,402
11,005
14,610
18,850
30,298
59,845
15,550
15,990
17,991
19,508
22,573
23,308
61,881
11,478
8,186
8,186
9,562
7,513
7,481
8,594
5,114
4,744
4,000
4,064
4,0644,0004,7445,1148,5947,4817,5139,5628,1868,18611,47861,88123,30822,57319,50817,99115,99015,55059,84530,29818,85014,61011,00511,40212,69412,3384,1364,5153,7644,1029,42118,59716,1147,9147,2686,4537,0217,7228,4199,73710,32111,70912,26313,03914,52014,22113,91113,3329,42212,4459,7338,6438,4428,9809,0358,87110,05810,63325,28527,32518,27416,87413,15613,59712,69513,76911,656007,4900009,586000
   > Total Current Liabilities 
0
0
0
2,242
0
0
0
5,034
0
0
6,526
7,751
7,542
9,336
9,811
5,878
6,648
10,487
11,086
6,280
6,637
3,949
9,035
3,997
3,960
5,769
9,732
9,564
4,944
9,683
9,926
7,538
449
9,011
180
127
274
8,805
8,419
3,375
7,021
6,453
3,680
4,486
9,384
10,303
6,357
1,312
3,718
4,508
4,134
1,088
8,783
8,701
8,836
8,363
11,844
12,151
11,707
10,390
10,763
12,347
14,268
11,605
21,632
60,496
10,336
7,331
7,331
9,190
7,513
7,481
7,602
4,404
4,469
3,777
3,777
3,7773,7774,4694,4047,6027,4817,5139,1907,3317,33110,33660,49621,63211,60514,26812,34710,76310,39011,70712,15111,8448,3638,8368,7018,7831,0884,1344,5083,7181,3126,35710,3039,3844,4863,6806,4537,0213,3758,4198,8052741271809,0114497,5389,9269,6834,9449,5649,7325,7693,9603,9979,0353,9496,6376,28011,08610,4876,6485,8789,8119,3367,5427,7516,526005,0340002,242000
       Short-term Debt 
0
0
0
998
0
0
0
2,651
0
0
4,402
5,081
4,641
4,344
3,943
2,675
4,074
7,341
7,549
3,881
4,007
1,130
5,832
922
1,118
5,647
5,696
2,307
189
9,584
9,633
3,000
4,000
8,784
4,000
4,000
4,000
4,000
3,957
2,976
1,990
998
0
1,267
5,640
14,335
5,676
0
-171
-206
957
1,958
2,961
3,965
523
9,930
1,878
343
285
291
297
303
309
314
320
3,600
3,444
0
279
338
255
0
86
109
110
0
111
111011010986025533827903,4443,6003203143093032972912853431,8789,9305233,9652,9611,958957-206-17105,67614,3355,6401,26709981,9902,9763,9574,0004,0004,0004,0008,7844,0003,0009,6339,5841892,3075,6965,6471,1189225,8321,1304,0073,8817,5497,3414,0742,6753,9434,3444,6415,0814,402002,651000998000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,976
0
0
0
717
0
0
0
0
0
0
0
0
0
0
0
0
1,504
0
0
0
0
0
0
0
0
2,936
2,971
0
0
0
0
0
0
0
0
0
0
00000000002,9712,936000000001,5040000000000007170002,976000000000000000000000000000000000000000
       Accounts payable 
0
0
0
317
0
0
0
679
0
0
238
300
499
550
479
163
131
138
210
34
75
190
343
125
513
122
261
434
263
99
293
341
449
227
180
127
274
187
52
399
48
447
196
172
261
357
681
1,312
534
1,109
707
1,088
2,918
4,201
4,428
1,627
2,622
3,309
3,851
4,264
3,750
4,123
3,761
3,655
3,637
3,095
3,112
3,468
3,468
2,513
1,992
1,926
1,997
1,601
1,462
1,689
1,689
1,6891,6891,4621,6011,9971,9261,9922,5133,4683,4683,1123,0953,6373,6553,7614,1233,7504,2643,8513,3092,6221,6274,4284,2012,9181,0887071,1095341,312681357261172196447483995218727412718022744934129399263434261122513125343190753421013813116347955049930023800679000317000
       Other Current Liabilities 
0
0
0
927
0
0
0
1,704
0
0
1,886
2,370
2,401
4,442
5,389
3,040
2,443
3,008
3,326
2,366
2,555
2,630
2,860
2,950
2,329
2,874
3,775
6,822
4,492
3,649
3,986
4,197
4,337
4,028
4,254
4,713
4,145
4,618
4,411
4,346
4,983
5,008
3,485
3,597
3,483
3,442
2,851
2,751
3,184
3,398
2,277
-2,468
2,568
233
3,585
-3,546
6,974
8,179
7,288
5,633
6,416
7,563
9,841
7,238
17,278
53,283
3,200
1,456
3,035
5,734
4,622
3,239
4,946
2,235
2,240
221
1,338
1,3382212,2402,2354,9463,2394,6225,7343,0351,4563,20053,28317,2787,2389,8417,5636,4165,6337,2888,1796,974-3,5463,5852332,568-2,4682,2773,3983,1842,7512,8513,4423,4833,5973,4855,0084,9834,3464,4114,6184,1454,7134,2544,0284,3374,1973,9863,6494,4926,8223,7752,8742,3292,9502,8602,6302,5552,3663,3263,0082,4433,0405,3894,4422,4012,3701,886001,704000927000
   > Long-term Liabilities 
0
0
0
7,344
0
0
0
2,456
0
0
5,130
6,018
5,154
4,261
3,345
10,996
11,626
16,838
14,198
4,352
3,421
4,921
4,114
4,983
4,482
2,874
1
2,881
4,478
3,649
3,985
6,684
14,071
4,028
12,083
11,582
10,047
932
0
4,347
0
0
3,587
3,428
6,730
8,294
3,064
2,790
47
7
2
11,250
3,911
2,701
2,169
6,248
7,006
18,147
48,138
5,160
5,227
5,644
5,240
10,968
1,676
1,385
1,142
855
855
372
2,891
0
992
710
275
223
287
28722327571099202,8913728558551,1421,3851,67610,9685,2405,6445,2275,16048,13818,1477,0066,2482,1692,7013,91111,25027472,7903,0648,2946,7303,4283,587004,347093210,04711,58212,0834,02814,0716,6843,9853,6494,4782,88112,8744,4824,9834,1144,9213,4214,35214,19816,83811,62610,9963,3454,2615,1546,0185,130002,4560007,344000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,957
3,425
2,881
4,478
8,584
7,633
6,684
5,735
4,784
3,828
2,868
1,903
932
0
0
0
0
0
550
5,116
7,830
1,237
0
0
0
0
0
0
0
0
4,403
4,462
4,520
4,579
2,728
2,763
3,434
3,204
9,168
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000009,1683,2043,4342,7632,7284,5794,5204,4624,403000000001,2377,8305,116550000009321,9032,8683,8284,7845,7356,6847,6338,5844,4782,8813,4253,9570000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
729
0
0
0
0
0
0
0
0
1,872
5,669
4,749
472
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,588
2,878
1,614
463
213
39
46
7
2
5,294
3,911
2,701
2,169
6,248
6,306
17,521
47,586
4,683
2,062
1,887
1,793
1,637
1,594
1,385
1,142
855
408
372
0
0
992
512
0
0
0
000512992003724088551,1421,3851,5941,6371,7931,8872,0624,68347,58617,5216,3066,2482,1692,7013,9115,2942746392134631,6142,8783,5880000000000000000000005004724,7495,6691,872000000007290000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,292
3,910
2,701
2,169
1,844
1,844
1,258
1,258
702
702
702
702
615
615
0
0
0
0
0
0
0
0
0
0
0
0
0000000000006156157027027027021,2581,2581,8441,8442,1692,7013,9105,292000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
1,975
0
0
0
28,574
0
0
13,003
45,282
37,394
26,798
17,172
11,405
18,907
9,294
3,354
5,581
6,122
2,899
5,708
29,707
25,236
20,426
27,265
20,041
15,131
17,192
16,812
11,875
18,703
13,842
12,401
14,679
17,231
14,673
10,467
6,664
7,315
1,432
7,742
3,673
-1,259
-3,609
1,155
2,939
17,946
38,005
51,047
76,367
65,874
39,110
36,049
31,662
28,573
13,392
-15,662
24,106
21,568
19,153
17,083
14,488
12,708
58,119
79,220
46,072
46,072
32,363
20,943
3,661
7,758
6,738
3,083
6,663
6,663
6,6636,6633,0836,7387,7583,66120,94332,36346,07246,07279,22058,11912,70814,48817,08319,15321,56824,106-15,66213,39228,57331,66236,04939,11065,87476,36751,04738,00517,9462,9391,155-3,609-1,2593,6737,7421,4327,3156,66410,46714,67317,23114,67912,40113,84218,70311,87516,81217,19215,13120,04127,26520,42625,23629,7075,7082,8996,1225,5813,3549,29418,90711,40517,17226,79837,39445,28213,0030028,5740001,975000
   Common Stock
0
0
0
5
0
0
0
6
0
0
6
168
168
168
169
169
300
300
308
374
449
75
75
279
279
279
367
368
368
397
416
418
556
556
586
636
672
689
689
696
744
744
1,064
72
85
132
744
27
69
83
122
310
310
36
6
88
77
285
8
8
8
5
5
6
6
8
18
18
18
20
23
1
3
3
3
0
23
2303331232018181886655888285778863631031012283692774413285721,064744744696689689672636586556556418416397368368367279279279757544937430830030016916916816816860060005000
   Retained Earnings Total Equity000000000000-519,701-514,827-506,291-501,112-497,508-493,197-468,140-439,386-423,466-418,990-392,222-385,085-345,993-334,759-325,142-315,148-308,308-300,941-296,507-289,984-284,989-277,581-270,810-266,660-259,256-252,082-245,901-240,187-232,685-225,953-219,380-213,076-206,754-200,172-193,146-187,299-182,345-176,712-168,656-161,3580000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-88
0
0
0
-66
0
0
-48
-42
-37
-26
-47
13
5
2
0
-1,248
-1,248
0
0
-1,575
0
0
0
1
1
0
0
-2,070
-2,070
0
0
-2,244
-2,244
0
0
-2,433
-2,433
0
0
-2,622
-2,622
0
-6,773
-2,761
-19
-19
-4
-2,966
1
1
-2
-3,141
-3,141
0
-9
-8
-56
-29
-74
-121
-102
-109
-107
0
-92
-72
-68
0
-93
-95
-94
0
-88
-880-94-95-930-68-72-920-107-109-102-121-74-29-56-8-90-3,141-3,141-211-2,966-4-19-19-2,761-6,7730-2,622-2,62200-2,433-2,43300-2,244-2,24400-2,070-2,0700011000-1,57500-1,248-1,24802513-47-26-37-42-4800-66000-88000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
181,505
195,554
196,385
197,109
204,093
209,542
211,629
224,900
226,362
231,194
239,997
249,244
254,170
255,679
258,050
265,827
267,347
277,488
281,182
283,645
286,243
296,918
303,853
326,185
353,061
376,057
410,816
411,556
424,158
428,264
450,564
451,949
452,492
452,486
517,311
519,131
520,288
523,442
529,429
532,504
0
0
0
0
0
0
0
0
0
0
0
0
000000000000532,504529,429523,442520,288519,131517,311452,486452,492451,949450,564428,264424,158411,556410,816376,057353,061326,185303,853296,918286,243283,645281,182277,488267,347265,827258,050255,679254,170249,244239,997231,194226,362224,900211,629209,542204,093197,109196,385195,554181,5050000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
19,179
0
0
0
63,389
0
0
67,628
108,589
109,194
109,942
110,535
112,531
126,710
127,461
133,523
138,575
143,789
145,199
152,359
181,718
180,758
181,505
195,554
196,385
197,109
204,093
209,542
211,629
224,901
226,362
231,195
242,241
249,244
254,170
255,679
260,484
265,827
267,347
277,488
283,804
283,645
286,243
296,918
306,614
326,185
353,080
376,061
413,781
411,555
424,157
428,266
453,705
451,949
452,492
452,478
517,302
519,123
520,288
523,442
529,429
532,504
581,823
620,611
-92
622,906
626,966
627,350
-88
634,697
636,660
636,950
0
642,302
642,3020636,950636,660634,697-88627,350626,966622,906-92620,611581,823532,504529,429523,442520,288519,123517,302452,478452,492451,949453,705428,266424,157411,555413,781376,061353,080326,185306,614296,918286,243283,645283,804277,488267,347265,827260,484255,679254,170249,244242,241231,195226,362224,901211,629209,542204,093197,109196,385195,554181,505180,758181,718152,359145,199143,789138,575133,523127,461126,710112,531110,535109,942109,194108,58967,6280063,38900019,179000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,678
Cost of Revenue-3,130
Gross Profit5,5485,548
 
Operating Income (+$)
Gross Profit5,548
Operating Expense-20,187
Operating Income-14,639-14,639
 
Operating Expense (+$)
Research Development2,315
Selling General Administrative10,324
Selling And Marketing Expenses7,548
Operating Expense20,18720,187
 
Net Interest Income (+$)
Interest Income0
Interest Expense-26
Other Finance Cost-125
Net Interest Income-151
 
Pretax Income (+$)
Operating Income-14,639
Net Interest Income-151
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,335-17,943
EBIT - interestExpense = -14,665
-11,335
-11,361
Interest Expense26
Earnings Before Interest and Taxes (EBIT)-14,639-11,309
Earnings Before Interest and Taxes (EBITDA)-14,485
 
After tax Income (+$)
Income Before Tax-11,335
Tax Provision--35
Net Income From Continuing Ops-26,158-11,300
Net Income-11,387
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses23,317
Total Other Income/Expenses Net3,304151
 

Technical Analysis of ReShape Lifesciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ReShape Lifesciences Inc. The general trend of ReShape Lifesciences Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ReShape Lifesciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ReShape Lifesciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.1912 < 0.201 < 0.209.

The bearish price targets are: 0.1601 > 0.158 > 0.1456.

Tweet this
ReShape Lifesciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ReShape Lifesciences Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ReShape Lifesciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ReShape Lifesciences Inc. The current macd is -0.00189894.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ReShape Lifesciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ReShape Lifesciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ReShape Lifesciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ReShape Lifesciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartReShape Lifesciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ReShape Lifesciences Inc. The current adx is 28.40.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy ReShape Lifesciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
ReShape Lifesciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ReShape Lifesciences Inc. The current sar is 0.19722014.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ReShape Lifesciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ReShape Lifesciences Inc. The current rsi is 48.52. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
ReShape Lifesciences Inc Daily Relative Strength Index (RSI) ChartReShape Lifesciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ReShape Lifesciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ReShape Lifesciences Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
ReShape Lifesciences Inc Daily Stochastic Oscillator ChartReShape Lifesciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ReShape Lifesciences Inc. The current cci is -16.37241288.

ReShape Lifesciences Inc Daily Commodity Channel Index (CCI) ChartReShape Lifesciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ReShape Lifesciences Inc. The current cmo is -0.49483519.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ReShape Lifesciences Inc Daily Chande Momentum Oscillator (CMO) ChartReShape Lifesciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ReShape Lifesciences Inc. The current willr is -52.66272189.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that ReShape Lifesciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ReShape Lifesciences Inc Daily Williams %R ChartReShape Lifesciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ReShape Lifesciences Inc.

ReShape Lifesciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ReShape Lifesciences Inc. The current atr is 0.01245872.

ReShape Lifesciences Inc Daily Average True Range (ATR) ChartReShape Lifesciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ReShape Lifesciences Inc. The current obv is 332,410,926.

ReShape Lifesciences Inc Daily On-Balance Volume (OBV) ChartReShape Lifesciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ReShape Lifesciences Inc. The current mfi is 47.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
ReShape Lifesciences Inc Daily Money Flow Index (MFI) ChartReShape Lifesciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ReShape Lifesciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

ReShape Lifesciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ReShape Lifesciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.519
Ma 20Greater thanMa 500.169
Ma 50Greater thanMa 1000.168
Ma 100Greater thanMa 2000.207
OpenGreater thanClose0.167
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ReShape Lifesciences Inc with someone you think should read this too:
  • Are you bullish or bearish on ReShape Lifesciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ReShape Lifesciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ReShape Lifesciences Inc

I send you an email if I find something interesting about ReShape Lifesciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about ReShape Lifesciences Inc.

Receive notifications about ReShape Lifesciences Inc in your mailbox!